Severe colitis complicating secukinumab (Cosentyx®) therapy

被引:6
作者
Lee, A. S. W. [1 ]
Levell, N. J. [1 ]
Shah, S. N. [1 ]
Gaffney, K. [2 ]
Tremelling, M. A. W. [3 ]
机构
[1] Norfolk & Norwich Univ Hosp, Dept Dermatol, Colney Lane, Norwich NR4 7UY, Norfolk, England
[2] Norfolk & Norwich Univ Hosp, Dept Rheumatol, Colney Lane, Norwich NR4 7UY, Norfolk, England
[3] Norfolk & Norwich Univ Hosp, Dept Gastroenterol, Colney Lane, Norwich NR4 7UY, Norfolk, England
关键词
D O I
10.1111/ced.14149
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:344 / 345
页数:2
相关论文
共 5 条
[1]   Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis [J].
Baeten, Dominique ;
Sieper, Joachim ;
Braun, Juergen ;
Baraliakos, Xenofon ;
Dougados, Maxime ;
Emery, Paul ;
Deodhar, Atul ;
Porter, Brian ;
Martin, Ruvie ;
Andersson, Mats ;
Mpofu, Shephard ;
Richards, Hanno B. .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (26) :2534-2548
[2]  
Baraliakos X, 2018, CLIN EXP RHEUMATOL, V36, P50
[3]   The burden of inflammatory bowel disease in Europe [J].
Burisch, Johan ;
Jess, Tine ;
Martinato, Matteo ;
Lakatos, Peter L. .
JOURNAL OF CROHNS & COLITIS, 2013, 7 (04) :322-337
[4]   Interleukin-17 inhibition: role in psoriasis and inflammatory bowel disease [J].
Hohenberger, Megan ;
Cardwell, Leah A. ;
Oussedik, Elias ;
Feldman, Steven R. .
JOURNAL OF DERMATOLOGICAL TREATMENT, 2018, 29 (01) :13-18
[5]   Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial [J].
Hueber, Wolfgang ;
Sands, Bruce E. ;
Lewitzky, Steve ;
Vandemeulebroecke, Marc ;
Reinisch, Walter ;
Higgins, Peter D. R. ;
Wehkamp, Jan ;
Feagan, Brian G. ;
Yao, Michael D. ;
Karczewski, Marek ;
Karczewski, Jacek ;
Pezous, Nicole ;
Bek, Stephan ;
Bruin, Gerard ;
Mellgard, Bjoern ;
Berger, Claudia ;
Londei, Marco ;
Bertolino, Arthur P. ;
Tougas, Gervais ;
Travis, Simon P. L. .
GUT, 2012, 61 (12) :1693-1700